Skip to main content

Advertisement

SpringerLink
Log in

Chronic pelvic pain syndrome and the overactive bladder: The inflammatory link

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Although the causes of chronic prostatitis/chronic pelvic pain syndrome, painful bladder syndrome/interstitial cystitis, and overactive bladder remain unclear, inflammation may explain some of the causative and propagating features. Cytokines may play a role by recruiting inflammatory cells and ultimately in inducing symptoms. This paper reviews the role of cytokines in the pathophysiology of chronic prostatitis/chronic pelvic pain syndrome, overactive bladder, and painful bladder syndrome/interstitial cystitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Wenninger K, Heiman JR, Rothman I, et al.: Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996, 155:965–968.

    Article  PubMed  CAS  Google Scholar 

  2. Oppenheim J, Feldman M: Cytokine Reference. San Diego: Academic Press; 2001.

    Google Scholar 

  3. Jacob CO, McDevitt HO: Tumour necrosis factor-alpha in murine autoimmune ‘lupus’ nephritis. Nature 1988, 331:356–358.

    Article  PubMed  CAS  Google Scholar 

  4. Roitt I, Brostoff J, Male D: Immunology, edn 4. Philadelphia: Lippincott-Raven; 1996.

    Google Scholar 

  5. Krieger JN, Nyberg L Jr, Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999, 282:236–237.

    Article  PubMed  CAS  Google Scholar 

  6. Nickel JC: Prostatitis and related conditions. In Campbell’s Urology, edn 8. Edited by Walsh PC, Retik AB, Vaughan ED, et al. Philadelphia: WB Saunders; 2002:603–630.

    Google Scholar 

  7. Schaeffer AJ, Knauss JS, Landis JR, et al.: Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002, 168:1048–1053.

    Article  PubMed  Google Scholar 

  8. Schaeffer AJ, Landis JR, Knauss JS, et al.: Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002, 168:593–598.

    Article  PubMed  Google Scholar 

  9. Pontari MA, Ruggieri MR: Mechanisms in prostatitis/ chronic pelvic pain syndrome. J Urol 2004, 172:839–845.

    Article  PubMed  Google Scholar 

  10. Moon TD, Hagen L, Heisey DM: Urinary symptomatology in younger men. Urology 1997, 50:700–703.

    Article  PubMed  CAS  Google Scholar 

  11. Naber KG, Weidner W: Chronic prostatitis: an infectious disease? J Antimicrob Chemother 2000, 46:157–161.

    Article  PubMed  CAS  Google Scholar 

  12. Alexander RB, Brady F, Ponniah S: Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. Urology 1997, 50:893–899.

    Article  PubMed  CAS  Google Scholar 

  13. John H, Maake C, Barghorn A, et al.: Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity. Andrologia 2003, 35:294–299.

    Article  PubMed  CAS  Google Scholar 

  14. Nickel JC, Alexander RB, Schaeffer AJ, et al.: Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003, 170:818–822.

    Article  PubMed  Google Scholar 

  15. Nadler RB, Koch AE, Calhoun EA, et al.: IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000, 164:214–218.

    Article  PubMed  CAS  Google Scholar 

  16. Hochreiter WW, Nadler RB, Koch AE, et al.: Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000, 56:1025–1029.

    Article  PubMed  CAS  Google Scholar 

  17. Shahed AR, Shoskes DA: Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 2001, 166:1738–1741.

    Article  PubMed  CAS  Google Scholar 

  18. Alexander RB, Ponniah S, Hasday J, Hebel JR: Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998, 52:744–749.

    Article  PubMed  CAS  Google Scholar 

  19. Orhan I, Onur R, Ilhan N, Ardicoglu A: Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. Int J Urol 2001, 8:495–499.

    Article  PubMed  CAS  Google Scholar 

  20. Miller LJ, Fischer KA, Goralnick SJ, et al.: Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 2002, 167(2 Pt 1):753–756.

    PubMed  CAS  Google Scholar 

  21. Miller LJ, Fischer KA, Goralnick SJ, et al.: Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002, 59:603–608.

    Article  PubMed  Google Scholar 

  22. Penna G, Mondaini N, Amuchastegui S, et al.: Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 2007, 51:524–533.

    Article  PubMed  CAS  Google Scholar 

  23. Elkayam O, Yaron I, Shirazi I, et al.: Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 2000, 19:101–105.

    Article  PubMed  CAS  Google Scholar 

  24. Straub RH, Herfarth HH, Rinkes B, et al.: Favorable role of interleukin 10 in patients with polymyalgia rheumatica. J Rheumatol 1999, 26:1318–1325.

    PubMed  CAS  Google Scholar 

  25. Khadra A, Fletcher P, Luzzi G, et al.: Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis. BJU Int 2006, 97:1043–1046.

    Article  PubMed  CAS  Google Scholar 

  26. Tyagi S, Thomas CA, Hayashi Y, Chancellor MB: The overactive bladder: epidemiology and morbidity. Urol Clin North Am 2006, 33:433–438, vii.

    Article  PubMed  Google Scholar 

  27. Galvin DJ, Watson RW, Gillespie JI, et al.: Mechanical stretch regulates cell survival in human bladder smooth muscle cells in vitro. Am J Physiol Renal Physiol 2002, 283:F1192–F1199.

    PubMed  CAS  Google Scholar 

  28. Hanno P: Interstitial cystitis and related disorders. In Campbell’s Urology, edn 8. Edited by Walsh PC, Retik AB, Vaughan ED, et al. Philadelphia: WB Saunders; 2002:631–670.

    Google Scholar 

  29. Jones CA, Nyberg L: Epidemiology of interstitial cystitis. Urology 1997, 49(5A Suppl):2–9.

    Article  PubMed  CAS  Google Scholar 

  30. Elbadawi A: Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 1997, 49(5A Suppl):14–40.

    Article  PubMed  CAS  Google Scholar 

  31. Sant GR, Theoharides TC: The role of the mast cell in interstitial cystitis. Urol Clin North Am 1994, 21:41–53.

    PubMed  CAS  Google Scholar 

  32. Felsen D, Frye S, Trimble LA, et al.: Inflammatory mediator profile in urine and bladder wash fluid of patients with interstitial cystitis. J Urol 1994, 152(2 Pt 1):355–361.

    PubMed  CAS  Google Scholar 

  33. Lamale LM, Lutgendorf SK, Zimmerman MB, Kreder KJ: Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. Urology 2006, 68:702–706.

    Article  PubMed  Google Scholar 

  34. Moldwin RM: Similarities between interstitial cystitis and male chronic pelvic pain syndrome. Curr Urol Rep 2002, 3:313–318.

    Article  PubMed  Google Scholar 

  35. Driscoll A, Teichman JM: How do patients with interstitial cystitis present? J Urol 2001, 166:2118–2120.

    Article  PubMed  CAS  Google Scholar 

  36. Parsons CL, Albo M: Intravesical potassium sensitivity in patients with prostatitis. J Urol 2002, 168:1054–1057.

    Article  PubMed  Google Scholar 

  37. Yilmaz U, Liu YW, Rothman I, et al.: Intravesical potassium chloride sensitivity test in men with chronic pelvic pain syndrome. J Urol 2004, 172:548–550.

    Article  PubMed  CAS  Google Scholar 

  38. Keay S, Zhang CO, Chai T, et al.: Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004, 63:22–26.

    Article  PubMed  Google Scholar 

  39. Dupont MC, Spitsbergen JM, Kim KB, et al.: Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 2001, 166:1111–1118.

    Article  PubMed  CAS  Google Scholar 

  40. Pezzone M, King W, Fraser A: Bi-directional, cross-sensitization of the urinary bladder and distal colon of the rat [AUA abstract]. J Urol 2003, 169(Suppl):260.

    Google Scholar 

  41. Saban MR, Saban R, Hammond TG, et al.: LPS-sensory peptide communication in experimental cystitis. Am J Physiol Renal Physiol 2002, 282:F202–F210.

    PubMed  CAS  Google Scholar 

  42. Saban R, Gerard NP, Saban MR, et al.: Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism. Am J Physiol Renal Physiol 2002, 283:F616–F629.

    PubMed  Google Scholar 

  43. Batler RA, Sengupta S, Forrestal SG, et al.: Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha. J Urol 2002, 168:819–825.

    Article  PubMed  CAS  Google Scholar 

  44. Bjorling DE, Jerde TJ, Zine MJ, et al.: Mast cells mediate the severity of experimental cystitis in mice. J Urol 1999, 162:231–236.

    Article  PubMed  CAS  Google Scholar 

  45. Saban MR, Nguyen NB, Hammond TG, Saban R: Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol 2002, 160: 2095–2110.

    PubMed  CAS  Google Scholar 

  46. Saban R, Saban MR, Nguyen NB, et al.: Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice. Physiol Genomics 2001, 7:35–43.

    PubMed  CAS  Google Scholar 

  47. Lowe EM, Anand P, Terenghi G, et al.: Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997, 79:572–577.

    PubMed  CAS  Google Scholar 

  48. Jang J, Park EY, Seo SI, et al.: Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder. BJU Int 2006, 98:435–439.

    Article  PubMed  CAS  Google Scholar 

  49. Saito M, Kawatani M, Kinoshita Y, et al.: Effectiveness of an anti-inflammatory drug, loxoprofen, for patients with nocturia. Int J Urol 2005, 12:779–782.

    Article  PubMed  CAS  Google Scholar 

  50. Gonzalez RR, Fong T, Belmar N, et al.: Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis. J Urol 2005, 173:630–634.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Weill Cornell Medical College, 525 East 68th Street, Suite F-9 West, New York, NY, 10021, USA

    Rajiv Saini

Authors
  1. Rajiv Saini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ricardo R. Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexis E. Te
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajiv Saini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saini, R., Gonzalez, R.R. & Te, A.E. Chronic pelvic pain syndrome and the overactive bladder: The inflammatory link. Curr Urol Rep 9, 314–319 (2008). https://doi.org/10.1007/s11934-008-0054-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-008-0054-8

Keywords

Search

Navigation